secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001493152-23-020539
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics reports conversion of convertible debentures into 1,243,000 common shares
--------------------------------------------------------------------------------

- On June 2, 2023, $16,500 debenture converted into 33,000 shares at $0.50 per share.
- Also on June 2, 2023, $181,500 of other debentures converted into 1,210,000 shares at $0.15 per share.
- Outstanding shares increased from 42,981,659 to 44,224,659 as a result of these conversions.
- Remaining convertible debentures total $970,200 aggregate principal due through March 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223020539/0001493152-23-020539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223020539/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer